The study finds that COVID-19 vaccination can significantly reduce symptoms and improve well-being in patients suffering from post-COVID-19 conditions (PCC). Vaccination also lowered systemic markers of inflammation but did not entirely eliminate persistent SARS-CoV-2 antigens, which may continue to contribute to inflammation.
The Changing Landscape of Systemic Therapy in Kidney Cancer
While surgical approaches like nephrectomy and metastasectomy haven’t seen major breakthroughs, there were some data from late-breaking abstracts of phase III trials in systemic therapy